Aurinia Pharmaceuticals Inc. Quarterly Return On Assets in % from Q3 2021 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Aurinia Pharmaceuticals Inc. quarterly/annual Return On Assets history and growth rate from Q3 2021 to Q2 2024.
  • Aurinia Pharmaceuticals Inc. Return On Assets for the quarter ending June 30, 2024 was -9.4 %, a 36.7% increase year-over-year.
  • Aurinia Pharmaceuticals Inc. annual Return On Assets for 2023 was -14.8 %, a 33.2% increase from 2022.
  • Aurinia Pharmaceuticals Inc. annual Return On Assets for 2022 was -22.2 %, a 47.6% increase from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -9.4 +5.45 +36.7% Apr 1, 2024 Jun 30, 2024
Q1 2024 -11.5 +8.9 +43.5% Jan 1, 2024 Mar 31, 2024
Q4 2023 -14.8 +7.38 +33.2% Oct 1, 2023 Dec 31, 2023
Q3 2023 -15.2 +7.62 +33.3% Jul 1, 2023 Sep 30, 2023
Q2 2023 -14.8 +18.3 +55.2% Apr 1, 2023 Jun 30, 2023
Q1 2023 -20.4 +17 +45.4% Jan 1, 2023 Mar 31, 2023
Q4 2022 -22.2 +20.2 +47.6% Oct 1, 2022 Dec 31, 2022
Q3 2022 -22.9 +15.4 +40.3% Jul 1, 2022 Sep 30, 2022
Q2 2022 -33.1 Apr 1, 2022 Jun 30, 2022
Q1 2022 -37.5 Jan 1, 2022 Mar 31, 2022
Q4 2021 -42.4 Oct 1, 2021 Dec 31, 2021
Q3 2021 -38.3 Jul 1, 2021 Sep 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.